Literature DB >> 8379949

The role of conformational change in serpin structure and function.

P Gettins1, P A Patston, M Schapira.   

Abstract

Serpins are members of a family of structurally related protein inhibitors of serine proteinases, with molecular masses between 40 and 100kDa. In contrast to other, simpler, proteinase inhibitors, they may interact with proteinases as inhibitors, as substrates, or as both. They undergo conformational interconversions upon complex formation with proteinase, upon binding of some members to heparin, upon proteolytic cleavage at the reactive center, and under mild denaturing conditions. These conformational changes appear to be critical in determining the properties of the serpin. The structures and stabilities of these various forms may differ significantly. Although the detailed structural changes required for inhibition of proteinase have yet to be worked out, it is clear that the serpin does undergo a major conformational change. This is in contrast to other, simpler, families of protein inhibitors of serine proteinases, which bind in a substrate-like or product-like manner. Proteolytic cleavage of the serpin can result in a much more stable protein with new biological properties such as chemo-attractant behaviour. These structural transformations in serpins provide opportunities for regulation of the activity and properties of the inhibitor and are likely be important in vivo, where serpins are involved in blood coagulation, fibrinolysis, complement activation and inflammation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8379949     DOI: 10.1002/bies.950150705

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  17 in total

1.  Probing the serpin structural-transition mechanism in ovalbumin mutant R339T by proteolytic-cleavage kinetics of the reactive-centre loop.

Authors:  Yasuhiro Arii; Masaaki Hirose
Journal:  Biochem J       Date:  2002-04-15       Impact factor: 3.857

2.  Probing serpin reactive-loop conformations by proteolytic cleavage.

Authors:  W S Chang; M R Wardell; D A Lomas; R W Carrell
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

3.  Importance of the release of strand 1C to the polymerization mechanism of inhibitory serpins.

Authors:  W S Chang; J Whisstock; P C Hopkins; A M Lesk; R W Carrell; M R Wardell
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

4.  Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells.

Authors:  S Sheng; J Carey; E A Seftor; L Dias; M J Hendrix; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

5.  S-ovalbumin, an ovalbumin conformer with properties analogous to those of loop-inserted serpins.

Authors:  J A Huntington; P A Patston; P G Gettins
Journal:  Protein Sci       Date:  1995-04       Impact factor: 6.725

6.  Neuroserpin, an axonally secreted serine protease inhibitor.

Authors:  T Osterwalder; J Contartese; E T Stoeckli; T B Kuhn; P Sonderegger
Journal:  EMBO J       Date:  1996-06-17       Impact factor: 11.598

7.  Characterization of a myxoma virus-encoded serpin-like protein with activity against interleukin-1 beta-converting enzyme.

Authors:  F Petit; S Bertagnoli; J Gelfi; F Fassy; C Boucraut-Baralon; A Milon
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

8.  A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy.

Authors:  T Miyata; M Nangaku; D Suzuki; R Inagi; K Uragami; H Sakai; K Okubo; K Kurokawa
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

9.  Studies on inhibition of neutrophil cathepsin G by alpha 1-antichymotrypsin.

Authors:  P A Patston
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

10.  Molecular cloning of a serine proteinase inhibitor from Brugia malayi.

Authors:  P Yenbutr; A L Scott
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.